Sign in
AMPH Stock Price, Chart, Stats & News
Amphastar Pharmaceuticals, Inc.
Save
Amphastar Pharmaceuticals, Inc. (AMPH) does not currently pay a dividend.
1.05B
Market cap
8.16x
Current P/E
–
Forward P/E
AMPH chart
Fundamentals
Gross margin | 49.46% |
Operating margin | 19.50% |
Pretax margin | 17.17% |
Net margin | 13.63% |
Effective tax rate | 20.65% |
ROA | 6.02% |
ROE | 12.76% |
D/E | 0.83x |
Interest coverage ratio | 5.51x |
AMPH valuation
P/E | 8.16x |
P/S | 1.21x |
P/B | 1.11x |
P/CF | 5.59x |
P/FCF | 7.21x |
P/OCF | 5.59x |
PEG | -0.84x |
EV multiple | 1.99x |
About
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France.
Similar securities
Based on sector and market capitalization
Report issue